(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY

ST13

US500000088460299

Class

16, 35, 41

Filing

88460299

Registration

5963686

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

06/04/2026

Trademark type

Word

Nice classes

16, 35, 41

Filing date

06/05/2019

Registration date

01/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/03/2026

Last transaction

06/04/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

03/05/2019

First use in commerce

03/05/2019

Drawing code

4

Owner type

99

Owner location

Chicago, IL, US

Examiner

HOLTZ, ALLISON

Current location

Historical data usage

Holders and representatives

Holders

American Society for Transplantation and Cellular Therapy
A. T. (pessoa física)

Representatives

Kimberly A. Pendo CHICAGO LAW PARTNERS, LLC

Technical classification

Nice Classes

Class 16Class 35Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 16

Printed instructional and educational materials in the field of blood and marrow transplantation and related cellular therapies; publicationsjournals and newsletters in the field of blood and marrow transplantation and related cellular therapies

Class 35

Association servicespromoting educationadvocacy and research in the field of blood and marrow transplantation and related cellular therapies

Class 41

Educational servicesconductingorganizing and teaching seminarsworkshopseducational conferenceseducational symposiumswebinarsclassestrainingproviding educational examination services and educational testing servicesin the field of blood and marrow transplantation and related cellular therapies; publication of journals and newsletters in the field of blood and marrow transplantation and related cellular therapies

Publications

History of USPTO decisions and trademark events.

23 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

06/03/2026

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

06/03/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/18/2026

ES8R

TEAS SECTION 8 RECEIVED

01/07/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/14/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/14/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/10/2019

ALIE

ASSIGNED TO LIE

12/03/2019

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

11/27/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

11/27/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/27/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

11/27/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/27/2019

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

11/24/2019

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

11/24/2019

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

11/24/2019

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

11/24/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/27/2019

GNRT

NON-FINAL ACTION E-MAILED

08/27/2019

CNRT

NON-FINAL ACTION WRITTEN

08/27/2019

DOCK

ASSIGNED TO EXAMINER

08/27/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/19/2019

NWAP

NEW APPLICATION ENTERED

06/08/2019

Continuous trademark protection

Get notified about every new filing that threatens AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.